- Home
- XLO vs DTST Comparison
XLO vs DTST Comparison
Compare XLO & DTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XLO
- DTST
- Stock Information
- Founded
- XLO 2016
- DTST 2001
- Country
- XLO United States
- DTST United States
- Employees
- XLO N/A
- DTST N/A
- Industry
- XLO Biotechnology: Pharmaceutical Preparations
- DTST EDP Services
- Sector
- XLO Health Care
- DTST Technology
- Exchange
- XLO Nasdaq
- DTST Nasdaq
- Market Cap
- XLO 42.2M
- DTST 28.2M
- IPO Year
- XLO 2021
- DTST N/A
- Fundamental
- Price
- XLO $0.71
- DTST $3.50
- Analyst Decision
- XLO Buy
- DTST
- Analyst Count
- XLO 1
- DTST 0
- Target Price
- XLO $4.00
- DTST N/A
- AVG Volume (30 Days)
- XLO 435.6K
- DTST 33.5K
- Earning Date
- XLO 08-07-2025
- DTST 08-13-2025
- Dividend Yield
- XLO N/A
- DTST N/A
- EPS Growth
- XLO N/A
- DTST N/A
- EPS
- XLO N/A
- DTST 0.02
- Revenue
- XLO $9,274,000.00
- DTST $25,219,312.00
- Revenue This Year
- XLO $300.08
- DTST $12.57
- Revenue Next Year
- XLO $1.87
- DTST $9.29
- P/E Ratio
- XLO N/A
- DTST $151.10
- Revenue Growth
- XLO N/A
- DTST N/A
- 52 Week Low
- XLO $0.62
- DTST $2.93
- 52 Week High
- XLO $1.70
- DTST $6.82
- Technical
- Relative Strength Index (RSI)
- XLO 51.28
- DTST 45.63
- Support Level
- XLO $0.67
- DTST $3.33
- Resistance Level
- XLO $0.70
- DTST $3.65
- Average True Range (ATR)
- XLO 0.03
- DTST 0.12
- MACD
- XLO 0.01
- DTST 0.02
- Stochastic Oscillator
- XLO 88.85
- DTST 55.00
About XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.